Advertisement

Topics

TransEnterix Completes Sale of the Senhance™ Surgical System in Germany

06:55 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Chosen to establish program in robotic general and gynecologic surgery TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announc...

Other Sources for this Article

For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1 443-213-0501
invest@transenterix.com
or
Media Contact:
(For EU) Conrad Harrington, +44 (0)20 3178 8914
(For US) Hannah Dunning, +1 415-618-8750
TransEnterix-SVC@sardverb.com

NEXT ARTICLE

More From BioPortfolio on "TransEnterix Completes Sale of the Senhance™ Surgical System in Germany"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...